Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease

S Lim, JW Kim, G Targher - Trends in Endocrinology & Metabolism, 2021 - cell.com
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a chronic condition
characterized by hepatic fat accumulation combined with underlying metabolic …

Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals

KE Chan, TJL Koh, ASP Tang, J Quek… - The Journal of …, 2022 - academic.oup.com
Abstract Background and Aims Metabolic-associated fatty liver disease (MAFLD) was
proposed as a better definition of nonalcoholic fatty liver disease (NAFLD) to encompass the …

[HTML][HTML] MAFLD: How is it different from NAFLD?

C Gofton, Y Upendran, MH Zheng… - Clinical and molecular …, 2023 - ncbi.nlm.nih.gov
Abstract “Metabolic dysfunction-associated fatty liver disease (MAFLD)” is the term
suggested in 2020 to refer to fatty liver disease related to systemic metabolic dysregulation …

Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. A meta-analysis and systematic review of 12 620 736 individuals

J Quek, CH Ng, ASP Tang, N Chew, M Chan… - Endocrine Practice, 2022 - Elsevier
Objective The recent introduction of the term metabolic associated fatty liver disease
(MAFLD) sought to reclassify nonalcoholic fatty liver disease (NAFLD). MAFLD is thought to …

Mechanisms linking metabolic-associated fatty liver disease (MAFLD) to cardiovascular disease

OO Badmus, TD Hinds Jr, DE Stec - Current hypertension reports, 2023 - Springer
Abstract Purpose of Review Metabolic-associated fatty liver disease (MAFLD) is a condition
of fat accumulation in the liver that occurs in the majority of patients in combination with …

Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight

M Eslam, HB El-Serag, S Francque, SK Sarin… - Nature reviews …, 2022 - nature.com
Metabolic (dysfunction)-associated fatty liver disease (MAFLD) affects up to a third of the
global population; its burden has grown in parallel with rising rates of type 2 diabetes …

[HTML][HTML] Metabolic-associated fatty liver disease (MAFLD): a multi-systemic disease beyond the liver

E Kaya, Y Yilmaz - Journal of clinical and translational hepatology, 2022 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is a multisystemic clinical condition that presents
with a wide spectrum of extrahepatic manifestations, such as obesity, type 2 diabetes …

[HTML][HTML] Metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease

JH Moon, W Kim, BK Koo, NH Cho - Gut and liver, 2022 - ncbi.nlm.nih.gov
Methods Individuals from two community-based cohorts who were 40 to 70 years old were
prospectively followed for 16 years. MAFLD was defined as a high fatty liver index (FLI≥ 60) …

Metabolic-associated fatty liver disease: A selective review of pathogenesis, diagnostic approaches, and therapeutic strategies

M Habibullah, K Jemmieh, A Ouda, MZ Haider… - Frontiers in …, 2024 - frontiersin.org
Background Metabolic associated fatty liver disease (MAFLD) is a novel terminology
introduced in 2020 to provide a more accurate description of fatty liver disease associated …

[HTML][HTML] From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?

SH Kang, Y Cho, SW Jeong, SU Kim… - Clinical and …, 2021 - ncbi.nlm.nih.gov
There is some dissatisfaction with the term “nonalcoholic fatty liver disease (NAFLD),” which
overemphasizes alcohol and underemphasizes the importance of metabolic risk factors in …